Prelude Therapeutics Incorporated
PRLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,725 | -$31,231 | -$32,085 | -$28,731 |
| Dep. & Amort. | $425 | $433 | $435 | $489 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,814 | $3,832 | $3,774 |
| Change in WC | -$2,572 | $739 | -$6,876 | $4,287 |
| Other Non-Cash | $2,757 | $170 | $463 | -$563 |
| Operating Cash Flow | -$19,115 | -$26,075 | -$34,231 | -$20,744 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$20 | -$47 | -$53 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$24,664 | -$9,463 | -$7,328 |
| Inv. Sales/Matur. | $40,091 | $36,205 | $71,696 | $29,499 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $40,091 | $11,521 | $62,186 | $22,118 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$53 | -$155 | -$151 |
| Stock Issued | $0 | $92 | $0 | $124 |
| Stock Repurch. | $0 | $0 | -$5 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | -$2 | $0 | -$7 |
| Financing Cash Flow | -$5 | $37 | -$160 | -$34 |
| Forex Effect | $809 | $0 | $0 | $0 |
| Net Chg. in Cash | $21,780 | -$14,517 | $27,795 | $1,340 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,752 | $44,313 | $16,518 | $15,178 |
| End Cash | $47,532 | $29,796 | $44,313 | $16,518 |
| Free Cash Flow | -$19,115 | -$26,095 | -$34,278 | -$20,797 |